| Rank |
Title |
Year |
PubWeight™‹?› |
|
101
|
Biological rhythms in cell-mediated immunity: their relevance in rheumatology.
|
1984
|
0.76
|
|
102
|
The technical transition to CFC-free inhalers.
|
1997
|
0.76
|
|
103
|
Gram-negative nosocomial infection: incidence, pathogens, compromised host.
|
1988
|
0.76
|
|
104
|
Treating the elderly arthritic--the doctor's dilemma.
|
1988
|
0.75
|
|
105
|
The clinical effect of 4-(2'-nitrophenyl)2,6-dimethyl-3,5-dicarbomethoxy-1,4-dihydropyridine (BAY a 1040) on angina pectoris evaluated by sequential analysis.
|
1980
|
0.75
|
|
106
|
Effects of adalat (nifedipine) on left ventricular hemodynamics in angina pectoris: comparative study with propranolol.
|
1980
|
0.75
|
|
107
|
The cancer risk of breast cysts--pathological factors.
|
1989
|
0.75
|
|
108
|
Inhibition of the slow inward current by nifedipine in mammalian ventricular myocardium.
|
1980
|
0.75
|
|
109
|
The cardiac electrophysiological effects of nifedipine.
|
1980
|
0.75
|
|
110
|
Clinical factors influencing the risk of breast cancer in women with gross cysts.
|
1989
|
0.75
|
|
111
|
The selection of microorganisms for treatment with broad-spectrum cephalosporins.
|
1988
|
0.75
|
|
112
|
Effects of nifedipine on myocardial perfusion and ischemic injury in dogs.
|
1980
|
0.75
|
|
113
|
Studies on gamma-vinyl-GABA in Kuopio, Finland.
|
1988
|
0.75
|
|
114
|
Efficacy and tolerability with long-term administration of vigabatrin.
|
1988
|
0.75
|
|
115
|
Prinzmetal's variant form of angina pectoris re-evaluation of mechanisms.
|
1980
|
0.75
|
|
116
|
Ultrasound assessment response to therapy of clinically undetected breast cysts.
|
1989
|
0.75
|
|
117
|
The risks and benefits of current and new anti-epileptic drugs.
|
1988
|
0.75
|
|
118
|
A profile of vigabatrin.
|
1988
|
0.75
|
|
119
|
Clinical benefits of vigabatrin.
|
1988
|
0.75
|
|
120
|
Do we need novel anti-epileptic drugs?
|
1988
|
0.75
|
|
121
|
Suppression of repeatedly occurring ventricular fibrillation with nifedipine in variant form of angina pectoris.
|
1980
|
0.75
|
|
122
|
Focus on vigabatrin. Proceedings of a satellite symposium. 17th Epilepsy International Congress. Jerusalem, Israel, 6-11th September, 1987.
|
1988
|
0.75
|
|
123
|
Inhibition of aldose reductase from rat nervous tissue by metabolites of cyclandelate.
|
1984
|
0.75
|
|
124
|
Can today's treatment prevent tomorrow's obstruction?
|
1988
|
0.75
|
|
125
|
Inhibition of atherosclerosis in the rabbit by cyclandelate.
|
1984
|
0.75
|
|
126
|
A review of the effects of antihypertensive treatment with alpha 1-adrenoceptor antagonists on plasma lipid profiles.
|
1987
|
0.75
|
|
127
|
Molecular mechanisms of interferon action.
|
1988
|
0.75
|
|
128
|
Antimicrobial combinations: in vitro--in vivo comparison.
|
1988
|
0.75
|
|
129
|
Dosage and dosage interval of tobramycin in the newborn.
|
1988
|
0.75
|
|
130
|
Air flow obstruction--what are the problems for the clinician?
|
1988
|
0.75
|
|
131
|
Maintenance therapy of asthma--the right choice?
|
1988
|
0.75
|
|
132
|
Effect of antihypertensive therapy on plasma lipoproteins in essential hypertension.
|
1987
|
0.75
|
|
133
|
The diagnosis of obstructive lung disease.
|
1988
|
0.75
|
|
134
|
Managing the environment.
|
1988
|
0.75
|
|
135
|
Lipids and diet in relation to cardiovascular disease in Iceland.
|
1987
|
0.75
|
|
136
|
Alpha-interferons in malignant melanoma.
|
1988
|
0.75
|
|
137
|
The management of obstructive airways disease in a hostile environment. Proceedings of a symposium. Amsterdam, The Netherlands, 31st August-5th September 1987.
|
1988
|
0.75
|
|
138
|
Enoximone, a pharmacological bridge to transplantation.
|
1988
|
0.75
|
|
139
|
Genetic and environmental determinants of plasma lipoproteins relevant to coronary heart disease.
|
1987
|
0.75
|
|
140
|
Use of enoximone in patients awaiting cardiac transplant.
|
1988
|
0.75
|
|
141
|
Efficacy of enoximone in the management of refractory low output states following cardiac surgery.
|
1988
|
0.75
|
|
142
|
Terazosin in mild hypertension: experience in open trials.
|
1987
|
0.75
|
|
143
|
Oncogenes and the pathogenesis of human cancers: implications for cancer diagnosis and management.
|
1988
|
0.75
|
|
144
|
Pseudomonas bacteraemia--continuing concern.
|
1988
|
0.75
|
|
145
|
A study of the comparative effects of enoximone and dobutamine on urinary output after open heart surgery.
|
1988
|
0.75
|
|
146
|
Effects of enoximone in patients with low ejection fraction undergoing coronary artery bypass graft surgery.
|
1988
|
0.75
|
|
147
|
Comparison of the haemodynamic effects of alpha- and beta-blockade in essential hypertension.
|
1987
|
0.75
|
|
148
|
Comparison of haemodynamic efficacy of enoximone and dobutamine in coronary surgery patients.
|
1988
|
0.75
|
|
149
|
Characterisation of myocardial mechanical function in acute heart failure.
|
1988
|
0.75
|
|
150
|
Current opinion on the management of hypertension and cardiovascular risk factors.
|
1987
|
0.75
|